The MDC Mission

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) carries out basic biomedical research with the aim of understanding the molecular basis of health and disease, and translating these findings as quickly as possible into clinical application. The research involves the diagnosis and treatment of diseases, as well as their prevention.

MDC 25 years

Research Highlights

Cutting cancer’s lifeline

A new study in the journal Nature reveals that a small signaling molecule has the ability to cut off the blood supply to tumors. This allows the immune system’s T-cells to indirectly fight cancer.


The art of folding mitochondrial membranes

Oliver Daumke's lab figures out how the inner membranes of mitochondria "get their groove" and assume the complex shapes they need to carry out crucial cellular functions


Further research highlights


MDC researcher awarded prestigious grant to advance cardiovascular research

Prof. Holger Gerhardt of the Max Delbrück Center for Molecular Medicine (MDC) and an international team of collaborators receive a $6 million grant from the Fondation Leducq.


The last of their kind

To save the northern white rhino from extinction an international research team has chosen an unusual approach. They want to facilitate an in vitro fertilisation by transforming the animals’ skin cells into egg cells. Thomas Hildebrandt and Sebastian Diecke will present their project during the Long Night of the Sciences. When the bull, Sudan, his […]


Committed to Max Delbrück’s scientific legacy

The family of the man who gave his name to the MDC visited the Berlin research center and discovered the beginnings, history and prospects of molecular medicine in Berlin


Further news on MDC Insights